Investigating why a new brain cancer drug works in some patients but not others

Lead Researcher: Dr Kerrie McDonald

Institution: University of New South Wales

Funding: $352,266

Funding Duration: 2013 - 2015

‍

The Research

High expression levels of the tumour suppressor gene MIG-6 was associated with better survival in a group of glioblastoma patients treated with bevacizumab